In addition to targeting endothelial cells, Src inhibitors also effectively target cancer cells to suppress cell cycle progression, survival, and proliferation and are being used in treatment of leukemia with clinical trials for many types of solid tumors ongoing.76 Here, SRC is linked to cancer.